New Psoriasis clinical trials: 171 posted since Nov 2024

Name: New Psoriasis clinical trials
Creator: SpecStream
License: https://creativecommons.org/licenses/by/4.0/

The full list. New Psoriasis clinical trials: 171 rows for $8.55, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 7 rows a month. The new rows come each week by email, $19 a month.

Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, enrollment type, location countries and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.

For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/condition/psoriasis, and every list with its row count and price is at https://specstream.ai/data/lists.json.

Updated November 9, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).

171 clinical studies in psoriasis were first posted on ClinicalTrials.gov from November 15, 2024 to November 9, 2026; 64 have an industry sponsor and 117 are recruiting or about to. The newest, NCT07925957, was posted on November 9, 2026: VEGF and Nailfold Changes in Psoriasis (Al-Azhar University).

The request: Every new Psoriasis clinical trial on ClinicalTrials.gov, with the sponsor, phase, sites and the listed contact. $10 of credit on sign-up, no card.

Get new trials like these Watch a sponsor

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

171New trials
64Industry sponsored
117Recruiting or not yet
November 9, 2026Latest posted

Newest trials

The newest 100 of 171, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

First posted	NCT ID	Title	Sponsor	Phase	Status	Conditions	Enrollment	Countries	Source
November 9, 2026	NCT07925957	VEGF and Nailfold Changes in Psoriasis	Al-Azhar University	Observational	Completed	Psoriasis	79	Egypt	clinicaltrials.gov
November 6, 2026	NCT07920861	A Study of HB0017 Injection in Healthy Volunteers to Evaluate Safety and Tolerability of a Single Subcutaneous Injection in Low-Body-Weight...	Huabo Biopharm Co., Ltd.	Phase 1	Recruiting	Psoriasis, Ankylosing Spondylitis	90	China	clinicaltrials.gov
November 5, 2026	NCT07918560	Cosmetic Efficacy Evaluation of Hydraporin AI Cream in Individuals With Atopic Dermatitis and Psoriasis	Brainfarma Industria Química e Farmacêutica S/A	Not applicable	Not yet recruiting	Atopic Dermatitis, Psoriasis	42	Brazil	clinicaltrials.gov
November 4, 2026	NCT07915492	Comparison of Efficacy and Safety of Deucravacitinib Versus Methotrexate in the Treatment of Moderate-to-Severe Plaque Psoriasis .	Bangladesh Medical University	Phase 4	Active not recruiting	Psoriasis	106	Bangladesh	clinicaltrials.gov
November 3, 2026	NCT07914231	A Study to Assess the Safety and Effectiveness of COL-5671-PRO Capsules in Adults With Moderate-to-Severe Plaque Psoriasis	Coultreon Biopharma	Phase 2	Not yet recruiting	Plaque Psoriasis	100	Canada	clinicaltrials.gov
November 2, 2026	NCT07908641	Comparing the Extent to Which Apremilast is Made Available in the Body After Administration as an Extended-release or Immediate-release...	Amgen	Phase 1	Not yet recruiting	Psoriasis, Arthritis, Psoriatic, Oral Ulcer	114		clinicaltrials.gov
October 28, 2026	NCT07900659	Efficacy and Flexibility of Tildrakizumab Treatment in Patients With Moderate-to-severe Plaque Psoriasis and High Disease Burden	Clin4all	Observational	Active not recruiting	Psoriasis, Moderate to Severe Psoriasis	150	France	clinicaltrials.gov
October 23, 2026	NCT07892339	Efficacy of Crisaborole 2% Ointment Versus Tacrolimus 0.1% Ointment in the Treatment of Intertriginous and/or Anogenital Psoriasis.	Cairo University	Phase 3	Not yet recruiting	Psoriasis, Psoriasis Genital	40	Egypt	clinicaltrials.gov
October 21, 2026	NCT07885345	Definition of Novel Optoacoustic Biomarkers of Psoriasis and Psoriatic Arthritis	University of Erlangen-Nürnberg Medical School	Not applicable	Not yet recruiting	Psoriasis (PsO), Psoriasis Arthritis	192		clinicaltrials.gov
October 5, 2026	NCT07858591	Retinal Capillary Vessel Density and Foveal Avascular Zone Size in Patients With Psoriatic Arthritis: A Case-Control Study.	Bursa Yuksek Ihtisas Training and Research Hospital	Observational	Recruiting	Arthritic Psoriasis, Psoriasis (PsO), Retinal Vessels	135	Turkey (Türkiye)	clinicaltrials.gov
September 30, 2026	NCT07850310	A Clinical Trial of MK-8644 in Healthy Participants and Participants With Psoriasis (MK-8644-001)	Merck Sharp & Dohme LLC	Phase 1	Recruiting	Psoriasis, Healthy	132	Australia	clinicaltrials.gov
September 30, 2026	NCT07849101	Ceramol PSOR Cream as an Adjuvant Treatment in Patients With Mild-to-Moderate Psoriasis Treated With Narrowband UVB Phototherapy (CERAMOL...	Unifarco SpA	Not applicable	Not yet recruiting	Psoriasis, Psoriasis; Plaque, Psoriasis Vulgaris	128	Spain	clinicaltrials.gov
September 29, 2026	NCT07846813	Evidencing Vibroacoustic Sensing for Inflammatory Skin Disease Monitoring	University of Edinburgh	Observational	Not yet recruiting	Eczema, Psoriasis	20	United Kingdom	clinicaltrials.gov
September 25, 2026	NCT07841314	Comparative Study on Unani Formulation Vs Active Control in Plaque Psoriasis	National Institute of Unani Medicine, Bengaluru	Phase 2	Not yet recruiting	Chronic Plaque Psoriasis, Plaque Psoriasis, Psoriasis, Taqashshur al Jild	54	India	clinicaltrials.gov
September 24, 2026	NCT07839455	Oral and Topical Phytocannabinoids for Psoriasis	Federal University of Latin American Integration	Phase 2	Active not recruiting	Psoriasis Vulgaris	37	Brazil	clinicaltrials.gov
September 14, 2026	NCT07817394	Patient Study to Evaluate the Safety and Emollient Performance of Doublebase Once in the Treatment of Psoriasis	Dermal Laboratories Ltd	Not applicable	Not yet recruiting	Psoriasis	100		clinicaltrials.gov
September 11, 2026	NCT07816575	Comparative Efficacy of Alpha Hydroxy Acids With and Without Nanocarriers Versus Calcipotriol Plus Betamethasone in Treatment of Plaque...	Al-Azhar University	Not applicable	Completed	Psoriasis	80	Egypt	clinicaltrials.gov
September 4, 2026	NCT07804134	Skin-in-Sight: a Longitudinal Cohort Infrastructure for Standardized Remote Monitoring and the Evaluation of Digital Care Innovations in...	Medisch Spectrum Twente	Observational	Not yet recruiting	Psoriasis, Eczema/Atopic Dermatitis, Hidradenitis Suppurativa (HS)	1,000	Netherlands	clinicaltrials.gov
September 3, 2026	NCT07801495	A Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Moderate to Severe Psoriatic Arthritis	Novartis Pharmaceuticals	Phase 2	Recruiting	Moderate to Severe Psoriatic Arthritis	220	United States	clinicaltrials.gov
August 28, 2026	NCT07792928	A Study of HCXT-2001 Tablets and HCXT-2001 Tablets(A) in Healthy Adults	Shanghai Peptidstar Therapeutics Limited	Phase 1	Not yet recruiting	Psoriasis	40	New Zealand	clinicaltrials.gov
August 27, 2026	NCT07791199	Continued Access to Deucravacitinib for Adult SLE/SjD and Pediatric PsO/PsA Study Completers	Bristol-Myers Squibb	Phase 3	Not yet recruiting	Systemic Lupus Erythematosus, Sjögren's Disease, Psoriasis, Psoriatic Arthritis	2,300		clinicaltrials.gov
August 24, 2026	NCT07780929	A Prospective, Interventional, Exploratory Study Evaluating the Efficacy of Small-Molecule Compound XJH05 Ointment in the Treatment of...	Xijing Hospital	Not applicable	Recruiting	Psoriasis, Psoriasis (PsO)	3	China	clinicaltrials.gov
August 18, 2026	NCT07771673	Multi-Omic SignAtures of Inflammatory Cutaneous Diseases	Guy's and St Thomas' NHS Foundation Trust	Observational	Not yet recruiting	Inflammatory Skin Conditions	400		clinicaltrials.gov
August 7, 2026	NCT07752108	A Study of Zasocitinib in Adults With Non-pustular Palmoplantar Psoriasis	Takeda	Phase 3	Not yet recruiting	Palmoplantar Psoriasis	40		clinicaltrials.gov
August 5, 2026	NCT07746583	A Study of Guselkumab Given After Ustekinumab in Participants With Moderate to Severe Psoriasis in Routine Clinical Practice	Janssen-Cilag Kft.	Observational	Recruiting	Psoriasis	100	Hungary	clinicaltrials.gov
August 5, 2026	NCT07746479	A Study to Evaluate the Efficacy and Safety of LZM012 ( Psoriasis )	Livzon Pharmaceutical Group Inc.	Phase 3	Completed	Psoriasis	244	China	clinicaltrials.gov
August 4, 2026	NCT07744191	A Clinical Trial of Antiplatelets in Psoriasis	NYU Langone Health	Phase 4	Not yet recruiting	Psoriasis (PsO), Psoriatic Arthritis (PsA)	60	United States	clinicaltrials.gov
July 30, 2026	NCT07736651	Anti Inflammatory Diet With Physical Therapy on Psoriasis	Mahmoud Usama Mahmoud Ahmed	Not applicable	Completed	Psoriasis	60	Egypt	clinicaltrials.gov
July 30, 2026	NCT07736586	A Study of HL40626S Tablets in Healthy Adults	HighsLab Therapeutics Inc.	Phase 1	Recruiting	Skin Disease, Immune System Disease, Skin Diseases, Papulosquamous, Psoriasis (PsO)	64	Australia	clinicaltrials.gov
July 24, 2026	NCT07724366	A Clinical Trial of TQH3906 Capsules in Adult Patients With Moderate to Severe Plaque Psoriasis	Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.	Phase 3	Recruiting	Psoriasis	400	China	clinicaltrials.gov
July 22, 2026	NCT07719530	Phase II Clinical Trial of SHR-1139 Injection in Patients With Psoriasis	Guangdong Hengrui Pharmaceutical Co., Ltd	Phase 2	Recruiting	Psoriasis	60	China	clinicaltrials.gov
July 20, 2026	NCT07713212	Combined Fractional CO₂ Laser and Topical Corticosteroid Versus Topical Corticosteroid Only in the Treatment of Palmoplantar Psoriasis	Cairo University	Phase 4	Not yet recruiting	Psoriasis	32	Egypt	clinicaltrials.gov
July 17, 2026	NCT07712731	HPP737 in Adult Patients With Plaque Psoriasis	Newsoara Biopharma Co., Ltd.	Phase 3	Completed	Psoriasis	607	China	clinicaltrials.gov
July 17, 2026	NCT07712705	HPP737 in Adult Patients With Moderate-to-severe Plaque Psoriasis.	Newsoara Biopharma Co., Ltd.	Phase 3	Completed	Psoriasis	515	China	clinicaltrials.gov
July 16, 2026	NCT07709169	Psoriasis and Its Impact on Quality of Life Among Psoriatic Patients	Tanta University	Observational	Completed	Psoriasis, Quality of Life	170	Egypt	clinicaltrials.gov
July 16, 2026	NCT07707141	Safety and Efficacy of HPP737 in Adult Patients With Plaque Psoriasis	Newsoara Biopharma Co., Ltd.	Phase 2	Completed	Psoriasis	123	China	clinicaltrials.gov
July 9, 2026	NCT07693595	Nailfold Capillaroscopic Changes in Psoriasis	Al-Azhar University	Observational	Recruiting	Psoriasis	100	Egypt	clinicaltrials.gov
June 17, 2026	NCT07654751	A Remotely Conducted Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically	Janssen Research & Development, LLC	Phase 4	Recruiting	Psoriasis, Colitis, Ulcerative, Crohn Disease, Arthritis, Psoriatic	10	United States	clinicaltrials.gov
June 15, 2026	NCT07648836	Evaluation of Serum IL-41 Level in Patients With Ankylosing Spondylitis and Psoriatic Arthritis	Assiut University	Observational	Not yet recruiting	Ankylosing Spondylitis, Psoriasis	90		clinicaltrials.gov
June 15, 2026	NCT07648602	PPD™ CorEvitas™ Psoriasis (PSO) Early Treatment Response Non-Interventional Study	CorEvitas	Observational	Recruiting	Psoriasis	2,500	United States	clinicaltrials.gov
June 11, 2026	NCT07642544	Effects of Different Secukinumab Maintenance Regimens on Long-Term Outcomes in Patients With Psoriasis	The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School	Observational	Not yet recruiting	Psoriasis, Psoriasis (PsO)	120	China	clinicaltrials.gov
June 9, 2026	NCT07635043	Efficacy of Topical Tapinarof Versus Betamethasone in the Treatment of Plaque Psoriasis	Pakistan Institute of Medical Sciences	Phase 4	Not yet recruiting	Psoriasis (PsO)	120	Pakistan	clinicaltrials.gov
June 8, 2026	NCT07634016	Global Healthcare Study on Psoriasis	Julia Tatjana Maul	Observational	Recruiting	Psoriasis (PsO)	9,600	Switzerland	clinicaltrials.gov
June 4, 2026	NCT07626788	Pentoxifylline Add-On Therapy for Mild-to-Moderate Plaque Psoriasis	Wasuchon Chaichan	Not applicable	Not yet recruiting	Psoriasis	140	Thailand	clinicaltrials.gov
June 3, 2026	NCT07623486	Trial of HSK44459 Cream for the Management Plaque Psoriasis	Haisco Pharmaceutical Group Co., Ltd.	Phase 1/2	Active not recruiting	Psoriasis	180	China	clinicaltrials.gov
May 29, 2026	NCT07615712	PPD™ CorEvitas™ Psoriasis (PSO) Rapid Response Non-Interventional Study	CorEvitas	Observational	Recruiting	Psoriasis	2,500	United States	clinicaltrials.gov
May 29, 2026	NCT07615257	Managing Psychological Distress Through Mindfulness-based CBT to Evaluate Its Effectiveness on Self-compassion Among Psoriasis Patients:The...	Islamia University of Bahawalpur	Not applicable	Recruiting	Psoriasis	128	Pakistan	clinicaltrials.gov
May 18, 2026	NCT07594054	Inflammation Digital Biomarkers Validation Study	University of Oxford	Observational	Not yet recruiting	Psoriatic Arthritis, Psoriasis (PsO)	3,458		clinicaltrials.gov
May 13, 2026	NCT07582783	A Study of Persistence to Guselkumab Treatment in Participants With Moderate-to-Severe Plaque Psoriasis in Romania	Janssen Research & Development, LLC	Observational	Recruiting	Psoriasis	200	Romania	clinicaltrials.gov
May 12, 2026	NCT07581418	Comparison of Methotrexate and Tofacitinib in Chronic Plaque Psoriasis	Pak Emirates Military Hospital	Not applicable	Not yet recruiting	Chronic Plaque Psoriasis	88		clinicaltrials.gov
April 27, 2026	NCT07552792	Impact of Hand Rub Placement on Patient Trust and Disease Stigma	Huashan Hospital	Not applicable	Not yet recruiting	Noncommunicable Disease, Psoriasis	250		clinicaltrials.gov
April 27, 2026	NCT07552454	Picankibart in Palmoplantar Pustulosis	Xijing Hospital	Not applicable	Recruiting	Palmoplantar Pustulosis	60	China	clinicaltrials.gov
April 24, 2026	NCT07549828	Sebum Metabolomics and Lipidomics for Clinical Applications	National Taiwan University Hospital	Not applicable	Not yet recruiting	Acne, Atopic Dermatitis, Seborrheic Dermatitis, Psoriasis, Healthy Subjects (HS)	200		clinicaltrials.gov
April 22, 2026	NCT07546032	Clinical Study on the Medical Device PROXERA PSOMED 30 for the Treatment of Nail Psoriasis: Evaluation of Safety and Efficacy	ICIM International S.r.l.	Not applicable	Recruiting	Nail Psoriasis	21	Italy	clinicaltrials.gov
April 16, 2026	NCT07532486	A Study to Evaluate Comparative Efficacy and Safety of Guselkumab in High-dose and Extended-interval Versus Standard-dose in Chinese...	Second Affiliated Hospital, Zhejiang University, School of Medicine	Not applicable	Recruiting	Psoriasis	400	China	clinicaltrials.gov
April 15, 2026	NCT07530367	Tofacitinib Plus Imatinib in Moderate-to-Severe Palmoplantar Pustulosis	Second Affiliated Hospital, Zhejiang University, School of Medicine	Phase 3	Not yet recruiting	Palmoplantar Pustulosis (PPP)	135	China	clinicaltrials.gov
March 31, 2026	NCT07503652	Clinical Observation of Xeligekimab in the Treatment of Moderate to Severe Palmoplantar Pustulosis	First Hospital of China Medical University	Phase 4	Recruiting	Palmoplantar Pustulosis (PPP)	10	China	clinicaltrials.gov
March 27, 2026	NCT07498543	Impact of Clinical and Psychological Factors on Satisfaction With Treatment in Psoriatic Patients on Biological Therapy	Catholic University of the Sacred Heart	Observational	Completed	Psoriasis	52	Italy	clinicaltrials.gov
March 27, 2026	NCT07494396	An AI-Based Erythema Measurement System for Psoriasis Lesions	Khon Kaen University	Observational	Not yet recruiting	Psoriasis	50	Thailand	clinicaltrials.gov
March 24, 2026	NCT07489885	A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis	InventisBio Co., Ltd	Phase 2	Recruiting	Psoriasis	75	United States	clinicaltrials.gov
March 23, 2026	NCT07487831	The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease	University of California, San Francisco	Phase 4	Recruiting	Atopic Dermatitis (Eczema), Psoriasis	50	United States	clinicaltrials.gov
March 20, 2026	NCT07485764	Metformin Combined With Secukinumab for Moderate-to-Severe Plaque Psoriasis in Overweight or Obese Chinese Patients	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	Phase 4	Not yet recruiting	Psoriasis, Plaque Psoriasis, Moderate-to-severe Plaque Psoriasis, Overweight , Obesity	186	China	clinicaltrials.gov
March 18, 2026	NCT07481019	A Randomised Controlled Trial of ePROM-Guided Flexible Scheduling in Dermatology	National University Hospital, Singapore	Not applicable	Not yet recruiting	Chronic Dermatological Conditions, Eczema, Urticaria, Psoriasis, Acne	250		clinicaltrials.gov
March 13, 2026	NCT07471048	A Study to Evaluate the Impact of a Magnolia Officinalis Dietary Supplement on Immune Biomarkers in Subjects With Psoriasis	Sirt3 LLC	Not applicable	Recruiting	Psoriasis	100	United States	clinicaltrials.gov
March 6, 2026	NCT07455578	Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease	Seismic Therapeutic AU Pty Ltd	Phase 1	Recruiting	Autoimmune Diseases, Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Psoriasis (PsO), Cutaneous Lupus...	24	Australia	clinicaltrials.gov
March 5, 2026	NCT07451626	Clinical, Epidemiologic, and Therapeutic Characterization of Pediatric Psoriasis in the Costa Rican Social Security System	Caja Costarricense de Seguro Social	Observational	Not yet recruiting	Pediatric Psoriasis	300	Costa Rica	clinicaltrials.gov
March 4, 2026	NCT07449234	A Study of Guselkumab After Switching From Ustekinumab in Participants With Moderate to Severe Psoriasis	Janssen-Cilag Ltd.	Observational	Terminated	Psoriasis	9	Austria	clinicaltrials.gov
March 4, 2026	NCT07448428	Generalized Pustular Psoriasis Registry in Costa Rica	Caja Costarricense de Seguro Social	Observational	Not yet recruiting	Generalized Pustular Psoriasis, Generalized Pustular Psoriasis (GPP)	50	Costa Rica	clinicaltrials.gov
March 4, 2026	NCT07448402	Costa Rican Registry of IL-23 Inhibitors in Psoriatic Disease	Caja Costarricense de Seguro Social	Observational	Not yet recruiting	Psoriasis, Psoriasis Arthritis, Psoriasis (PsO)	50	Costa Rica	clinicaltrials.gov
March 4, 2026	NCT07448337	Psoriasis Comorbidities at Hospital Calderón Guardia	Caja Costarricense de Seguro Social	Observational	Not yet recruiting	Psoriasis, Psoriasis Arthritis, Psoriasis (PsO), Psoriasis Patients	350	Costa Rica	clinicaltrials.gov
February 25, 2026	NCT07434076	Cross-Sectional Study for an Ocular Imaging-Based Predictive Model of Inflammatory Skin Diseases Grounded in Traditional Chinese Medicine	Shanghai Yueyang Integrated Medicine Hospital	Observational	Not yet recruiting	Psoriasis, Atopic Dermatitis	950		clinicaltrials.gov
February 25, 2026	NCT07432815	Treatment of Psoriasis With Depression and/or Anxiety With Methotrexate vs Combined Methotrexate and Antidepressant	Cairo University	Phase 4	Completed	Depression, Anxiety, Psoriasis	40	Egypt	clinicaltrials.gov
February 25, 2026	NCT07432386	Methotrexate Versus Apremilast for Pruritus in Psoriasis	Zarmeen Khawar	Phase 4	Not yet recruiting	Psoriasis, Pruritus	80	Pakistan	clinicaltrials.gov
February 24, 2026	NCT07430319	Real-Life Evaluation of Guselkumab Dosing Interval Adjustments	Centre Hospitalier Universitaire de Nice	Observational	Recruiting	Psoriasis	100	France	clinicaltrials.gov
February 24, 2026	NCT07428954	Using Artificial Intelligence to Help Doctors Identify Different Skin Conditions and Improve Patient Care	AI Labs Group S.L	Observational	Completed	Dermatitis, Melanoma (Skin Cancer), Alopecia, Urticaria, Granuloma Annulare, Seborrheic Keratoses, Herpes, Tinea...	16	Spain	clinicaltrials.gov
February 24, 2026	NCT07428915	Evaluating Legit.Health Plus Support for Improving Diagnosis of Generalized Pustular Psoriasis and Other Skin Conditions Among Primary Care...	AI Labs Group S.L	Observational	Completed	Pustular Psoriasis (PP), Generalized Pustular Psoriasis (GPP), Eczema Atopic Dermatitis, Acute Generalized...	15	Spain	clinicaltrials.gov
February 23, 2026	NCT07426120	Efficacy and Safety of a Botanical Total Coumarin (TC) Cream in Treating Patients With Psoriasis Vulgaris (PLANTCOAT-III)	Psoriasis Research Institute of Guangzhou	Phase 3	Recruiting	Psoriasis Vulgaris, Topical Administration, Phase III	300	United States	clinicaltrials.gov
February 11, 2026	NCT07401992	Effects of Semaglutide on Clinical Outcomes and Metabolic Inflammation in Psoriasis	Hospital Universitario Dr. Jose E. Gonzalez	Phase 4	Recruiting	Psoriasis (PsO), Obesity & Overweight, Diabetes Mellitus - Type 2	62	Mexico	clinicaltrials.gov
February 5, 2026	NCT07391423	Assessing Psoriasis Treatment Outcomes	Wake Forest University Health Sciences	Not applicable	Not yet recruiting	Psoriasis	15	United States	clinicaltrials.gov
February 5, 2026	NCT07390487	The Effects of Audio-Based Therapy on Anxiety in Psoriasis	University of California, San Francisco	Not applicable	Recruiting	Psoriasis (PsO), Anxiety	120	United States	clinicaltrials.gov
February 2, 2026	NCT07382388	A Real-World Study on the Impact of Weight Loss on Treatment Efficacy in Overweight/Obese Patients With Plaque Psoriasis	Peking University Third Hospital	Observational	Not yet recruiting	Psoriasis	70		clinicaltrials.gov
January 29, 2026	NCT07375654	Combined Use of Cyclosporine and Metformin in Treatment of Psoriasis vs Cyclosporine Alone	Cairo University	Phase 1	Completed	Psoriasis	32	Egypt	clinicaltrials.gov
January 27, 2026	NCT07370766	Impact of Tildrakizumab on Patient Reported Outcomes in Patients With Moderate-to-severe Psoriasis in Canada	Chronicle Academy	Observational	Recruiting	Psoriasis (PsO), Moderate to Severe Psoriasis	80	Canada	clinicaltrials.gov
January 26, 2026	NCT07366268	Evaluation the Topical Apremilast Nanoformulation in Treatment of Localized Plaque Psoriasis	Assiut University	Not applicable	Not yet recruiting	Psoriasis	36		clinicaltrials.gov
January 23, 2026	NCT07362017	Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis	Vanda Pharmaceuticals	Phase 3	Recruiting	Moderate-to-severe Chronic Plaque Psoriasis	300	United States	clinicaltrials.gov
January 20, 2026	NCT07352566	Utilization of a Microdevice for Psoriasis and Atopic Dermatitis	University of California, San Francisco	Phase 4	Not yet recruiting	Psoriasis, Atopic Dermatitis	10	United States	clinicaltrials.gov
January 20, 2026	NCT07351448	Research on the Extraction of Tongue and Facial Diagnosis Features of Psoriasis Vulgaris in Traditional Chinese Medicine and Its...	Shanghai Yueyang Integrated Medicine Hospital	Observational	Not yet recruiting	Psoriasis (PsO), Traditional Chinese Medicine (TCM), Diagnosis	450	China	clinicaltrials.gov
January 14, 2026	NCT07340216	Maximal Usage Pharmacokinetics and Safety Study of ARQ-154 Foam 0.3% in Pediatric Participants With Scalp and Body Psoriasis	Arcutis Biotherapeutics, Inc.	Phase 1	Completed	Psoriasis	22	United States	clinicaltrials.gov
January 13, 2026	NCT07336641	LANDSCAPE: Demographics and Treatment Patterns of Patients With Immune-Mediated Inflammatory Skin Diseases in Italian Clinical Practice	Fondazione ISIDE	Observational	Not yet recruiting	Psoriasis, Atopic Dermatitis, Vitiligo, Alopecia Areata, Hidradenitis Suppurativa	20,000	Italy	clinicaltrials.gov
January 7, 2026	NCT07321288	Machine Learning-Based Prediction of Insulin Resistance in Psoriasis Patients Emphasizing Interpretability	Chinese PLA General Hospital	Observational	Active not recruiting	Psoriasis, Insulin Resistance	1,265	China	clinicaltrials.gov
January 2, 2026	NCT07314060	A Clinical Trial of TQH2929 Injection in Patients With Acute Flare-up of Generalized Pustular Psoriasis	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	Phase 2	Terminated	Generalized Pustular Psoriasis	36	China	clinicaltrials.gov
December 23, 2025	NCT07298265	Physician- vs Questionnaire-Based Screening for Psoriatic Arthritis in Psoriasis	Charite University, Berlin, Germany	Observational	Recruiting	Psoriasis (PsO), Psoriatic Arthritis (PsA)	500	Canada	clinicaltrials.gov
December 17, 2025	NCT07289399	Is There a Benefit From Addition of Treadmill Walking to Diet Restriction in Psoriasis Women With PCOS?	Cairo University	Not applicable	Recruiting	Psoriasis, Polycystic Ovary Syndrome	40	Egypt	clinicaltrials.gov
December 8, 2025	NCT07270003	A Prospective, Single-arm, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Ivarmacitinib in the Treatment of Palmoplantar...	Xijing Hospital	Not applicable	Recruiting	Palmoplantar Pustulosis (PPP)	60	China	clinicaltrials.gov
December 4, 2025	NCT07265284	A Study to Evaluate Efficacy and Safety of IBI112 in Adolescent Participants With Moderate to Severe Plaque Psoriasis	Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.	Phase 3	Recruiting	Psoriasis	104	China	clinicaltrials.gov
December 3, 2025	NCT07261306	Comparison Between Oral Methotrexate and Tofacitinib in Chronic Plaque Psoriasis	Lahore General Hospital	Early phase 1	Recruiting	Psoriasis	75	Pakistan	clinicaltrials.gov
December 2, 2025	NCT07258745	Pharmacokinetic, Safety, Tolerability, and Immunogenicity Comparison of CKD-704 (Risankizumab Biosimilar), With EU-approved Skyrizi®, and...	Chong Kun Dang Pharmaceutical	Phase 1	Recruiting	Psoriasis	213	Poland	clinicaltrials.gov
December 1, 2025	NCT07256015	Deucravacitinib for Patients With Moderate/Severe Psoriasis: A Real-Life Experience in Italy	Bristol-Myers Squibb	Observational	Active not recruiting	Psoriasis	200	Italy	clinicaltrials.gov
December 1, 2025	NCT07255781	Shared Pathways Between Non-Alcoholic Fatty Liver Disease and Psoriatic Disease With Guselekumab Therapy	University of California, San Diego	Observational	Withdrawn	Psoriasis (PsO), PsA (Psoriatic Arthritis), NAFLD (Nonalcoholic Fatty Liver Disease)	0		clinicaltrials.gov
November 28, 2025	NCT07254325	Pharmacokinetic, Safety and Immunogenicity Study of New Process CMAB015 and Cosentyx in Healthy Volunteers	Taizhou Mabtech Pharmaceutical Co.,Ltd	Phase 1	Completed	Psoriasis	114	China	clinicaltrials.gov

Sponsors posting most

Sponsor	New trials	Latest
Bristol-Myers Squibb	7	August 27, 2026
Cairo University	6	October 23, 2026
Xijing Hospital	4	August 24, 2026
Caja Costarricense de Seguro Social	4	March 5, 2026
Al-Azhar University	3	November 9, 2026
Newsoara Biopharma Co., Ltd.	3	July 17, 2026
Second Affiliated Hospital, Zhejiang University, School of Medicine	3	April 16, 2026
University of California, San Francisco	3	March 23, 2026
Shanghai Yueyang Integrated Medicine Hospital	3	February 25, 2026
South Valley University	3	August 19, 2025
Novartis Pharmaceuticals	2	September 3, 2026
Janssen Research & Development, LLC	2	June 17, 2026
Assiut University	2	June 15, 2026
CorEvitas	2	June 15, 2026
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School	2	June 11, 2026
Haisco Pharmaceutical Group Co., Ltd.	2	June 3, 2026
National University Hospital, Singapore	2	March 18, 2026
Centre Hospitalier Universitaire de Nice	2	February 24, 2026
AI Labs Group S.L	2	February 24, 2026
Charite University, Berlin, Germany	2	December 23, 2025

By phase

Phase	New trials	Latest
Observational	65	November 9, 2026
Not applicable	38	November 5, 2026
Phase 3	17	October 23, 2026
Phase 1	16	November 6, 2026
Phase 2	16	November 3, 2026
Phase 4	14	November 4, 2026
Early phase 1	3	December 3, 2025
Phase 1/2	1	June 3, 2026
Phase 2/3	1	March 7, 2025

By country

Country	New trials	Latest
China	35	November 6, 2026
United States	28	September 3, 2026
Egypt	16	November 9, 2026
Italy	9	April 22, 2026
France	8	October 28, 2026
Canada	7	November 3, 2026
Spain	7	September 30, 2026
Germany	7	November 24, 2025
Poland	6	December 2, 2025
Turkey (Türkiye)	5	October 5, 2026
Australia	5	September 30, 2026
United Kingdom	5	September 29, 2026
Hungary	5	August 5, 2026
Pakistan	4	June 9, 2026
Costa Rica	4	March 5, 2026
South Korea	4	October 21, 2025
Brazil	3	November 5, 2026
Netherlands	3	September 4, 2026
Mexico	3	February 11, 2026
Japan	3	November 17, 2025
New Zealand	2	August 28, 2026
Switzerland	2	June 8, 2026
Thailand	2	June 4, 2026
Romania	2	May 13, 2026
Belgium	2	November 18, 2025

Where the register publishes

U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.